MDC.L

Mediclinic International Plc
Mediclinic Intnl plc - Director/PDMR Shareholding
25th May 2023, 13:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 6902A
Mediclinic International plc
25 May 2023
 

Mediclinic International plc

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

South African income tax number: 9432434182

('Mediclinic', the 'Company', or the 'Group')

 

 

25 May 2023

 

NOTIFICATION: TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES & PERSONS CLOSELY ASSOCIATED WITH THEM

 

Vesting of awards under the Company's Short-Term Incentive ('STI') scheme and Long-Term Incentive Plan ('LTIP')

 

In connection with the recommended cash acquisition of Mediclinic by Manta Bidco Limited (a newly formed company owned by: (i) Remgro Limited and certain of its subsidiaries; and (ii) SAS Shipping Agencies Services S.à r.l., a wholly owned subsidiary of MSC Mediterranean Shipping Company SA) (the 'Acquisition'), this notification sets out the details of the vesting of awards over ordinary shares in Mediclinic granted under the Company's STI and LTIP to Directors and other persons discharging managerial responsibilities ('PDMRs') in the financial years ended on 31 March 2020, 31 March 2021, 31 March 2022 and 31 March 2023.

 

The awards vested on 24 May 2023 and will be settled in cash, based on the offer price to be paid by Manta Bidco Limited in connection with the Acquisition, being 501 pence per share.

 

The notifications that follow are made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr Carel Aron van der Merwe

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Executive Officer - Mediclinic International plc 

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   19 June 2019;

 

2.   14 December 2020;

 

3.   4 June 2021; and

 

4.   5 August 2022.

 

Vesting of deferred awards over ordinary shares in Mediclinic granted at nil cost under the Company's STI on:

 

5.   4 June 2021; and

 

6.   5 August 2022

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.              £nil

45 185

2.              £nil

176 093

3.              £nil

118 727

4.              £nil

49 524

5.              £nil

122 614

6.              £nil

74 718

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

586 861

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Petrus Jurgens Myburgh

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Financial Officer - Mediclinic International plc  

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   19 June 2019;

 

2.   14 December 2020;

 

3.   4 June 2021; and

 

4.   5 August 2022.

 

Vesting of deferred awards over ordinary shares in Mediclinic granted at nil cost under the Company's STI on:

 

5.   4 June 2021; and

 

6.   5 August 2022

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.              £nil

24 981

2.              £nil

97 549

3.              £nil

63 523

4.              £nil

30 900

5.              £nil

80 655

6.              £nil

47 488

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

345 096

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Gert Cornelis Hattingh

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Governance Officer - Mediclinic International plc 

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   14 December 2020;

 

2.   4 June 2021; and

 

3.   5 August 2022.

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.              £nil

37 839

2.              £nil

24 331

3.              £nil

5 983

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

68 153

 

£nil

 

e)

Date of the transaction

24 May 2023

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr Dirk Cornelius le Roux

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Information Officer - Mediclinic International plc 

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   14 December 2020;

 

2.   4 June 2021; and

 

3.   5 August 2022.

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.              £nil

29 654

2.              £nil

19 053

3.              £nil

4 677

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

53 384

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr Daniel Liedtke

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer: Hirslanden

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   14 December 2020;

 

2.   4 June 2021; and

 

3.   5 August 2022.

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.              £nil

70 352

2.              £nil

39 423

3.              £nil

10 849

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

120 624

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Magnus Oetiker

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Strategy Officer - Mediclinic International plc

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   14 December 2020;

 

2.   4 June 2021; and

 

3.   5 August 2022.

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.              £nil

56 587

2.              £nil

32 303

3.              £nil

10 822

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

99 712

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Koert Hendrik Stefanus Pretorius

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Operating Officer - Mediclinic International plc

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   14 December 2020;

 

2.   4 June 2021; and

 

3.   5 August 2022.

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.            £nil

39 509

2.            £nil

25 469

3.            £nil

6 261

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

71 239

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr René Toua

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Clinical Officer - Mediclinic International plc

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   14 December 2020;

 

2.   4 June 2021; and

 

3.   5 August 2022.

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.            £nil

30 301

2.            £nil

19 829

3.            £nil

4 915

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

55 045

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr Tyson Bruno Welzel

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Innovation Officer - Mediclinic International plc

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   14 December 2020;

 

2.   4 June 2021; and

 

3.   5 August 2022.

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1.            £nil

24 080

2.            £nil

15 896

3.            £nil

8 460

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

48 436

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Hein van Eck

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer - Mediclinic Middle East

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

4.   14 December 2020;

 

5.   4 June 2021; and

 

6.   5 August 2022.

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

4.            £nil

8 833

5.            £nil

5 011

6.            £nil

2 102

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

15 946

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Greg van Wyk

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer: Mediclinic Southern Africa

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Vesting of conditional awards over ordinary shares in Mediclinic granted at nil cost under the Company's LTIP on:

 

1.   14 December 2020;

 

2.   4 June 2021; and

 

3.   5 August 2022.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

4.            £nil

22 919

5.            £nil

14 800

6.            £nil

5 681

 

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

43 400

 

£nil

 

e)

Date of the transaction

24 May 2023

f)

Place of the transaction

Outside a trading venue

 

 

CONTACT INFORMATION

 

Investor queries

James Arnold, Head of Investor Relations, Mediclinic International plc

+44 (0)20 3786 8181

ir@mediclinic.com 

 

Media queries

FTI Consulting

Ben Atwell/Ciara Martin - UK

+44 (0)20 3727 1000

Sherryn Schooling - South Africa

+27 (0)21 487 9000

 

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom

Website: www.mediclinic.com

Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank

JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDGDUSBDDGXU ]]>
TwitterFacebookLinkedIn